Cancer · 2009 · 21 citations · 14 references
MedicineCancer BiologyOncologyCancer GeneticsMolecular OncologyUrologic OncologyBiomarkers In Urologic OncologyKidney CancerRenal Cell CarcinomaRenal DiseaseRenal NeoplasmsUrologic Cancer DiagnosisConference PresentationsKidney Cancer DiagnosisRenal Cell Carcinoma BiomarkersRenal Cell Carcinoma StagingRenal Cell Carcinoma Systemic TherapyRenal MalignancyRenal Tumor GradingSystemic Therapy Selection
The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.
14
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · New England Journal of Medicine · 2007 · 4.8K citations · Full text
Medicine, Nephrology, Oncology +11
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Gary R. Hudes, Michael A. Carducci, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 3.6K citations
Medicine, Oncology, Chemotherapy +10
Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer, Brian I. Rini, Ronald M. Bukowski et al. · JAMA · 2006 · 1.2K citations
Medicine, Oncology, Pharmacology +17